AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
Department of Medicine, Division of Cardiovascular Medicine
American Heart Association; Arteriosclerosis; Cardiovascular Diseases; Death, Sudden, Cardiac; Heart Arrest; Humans; Practice Guidelines as Topic; Preventive Medicine; Rehabilitation; United States
Cardiology | Cardiovascular Diseases
Since the original publication (in 1995) of the American Heart Association (AHA) consensus statement on secondary prevention, which was endorsed by the American College of Cardiology (ACC), important evidence from clinical trials has emerged that further supports the merits of aggressive risk reduction therapies for patients with atherosclerotic cardiovascular disease. As noted in that statement, aggressive risk factor management clearly improves patient survival, reduces recurrent events and the need for interventional procedures, and improves the quality of life for these patients. The compelling evidence from some recent clinical trials was the impetus to revise the 1995 guidelines.
Rights and Permissions
Citation: Circulation. 2001 Sep 25;104(13):1577-9.